Cumberland Pharmaceuticals Inc. (CPIX)
USD 4.9
(-5.5%)
USD 4.9
(-5.5%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 39.55 Million | 42.01 Million | 35.98 Million | 37.44 Million | 34.38 Million | 40.74 Million |
| Cost of Revenue | 6.06 Million | 9.11 Million | 8.81 Million | 8.65 Million | 7.42 Million | 7.37 Million |
| Gross Profit | 33.48 Million | 32.89 Million | 27.17 Million | 28.78 Million | 26.96 Million | 33.36 Million |
| Operating Expenses | 43.04 Million | 38.59 Million | 34.85 Million | 35.16 Million | 36.25 Million | 40.75 Million |
| Selling, General and Administrative Expenses | 29.1 Million | 26.84 Million | 24.79 Million | 24.96 Million | 25.25 Million | 30.66 Million |
| Research and Development Expenses | 5.83 Million | 6.68 Million | 5.68 Million | 5.77 Million | 6.86 Million | 7.32 Million |
| Other Expenses | 8.1 Million | 5.06 Million | 4.37 Million | 4.43 Million | 4.13 Million | 2.76 Million |
| Cost and Expenses | 49.1 Million | 47.71 Million | 43.66 Million | 43.82 Million | 43.67 Million | 48.13 Million |
| Operating Income | -6.21 Million | -5.7 Million | -7.67 Million | -6.38 Million | -9.28 Million | -7.39 Million |
| Interest Expense | 667.86 Thousand | 585.99 Thousand | 98.03 Thousand | 263.62 Thousand | 246.18 Thousand | 195.84 Thousand |
| Income Tax Expense | 45.76 Thousand | 68.85 Thousand | 34.89 Thousand | 55.9 Thousand | -79.31 Thousand | 16.63 Thousand |
| Earnings before Tax | -6.28 Million | -5.58 Million | -5.56 Million | -6.56 Million | -9.29 Million | -7.02 Million |
| Net Income | -6.27 Million | -5.65 Million | -5.59 Million | -6.62 Million | -9.21 Million | -6.96 Million |
| Earnings Per Share Basic | -0.44 | -0.39 | -0.38 | -0.44 | -0.60 | -0.45 |
| Earnings Per Share Diluted | -0.44 | -0.39 | -0.38 | -0.44 | -0.60 | -0.45 |
| Weighted Average Shares Outstanding | 14.29 Million | 14.56 Million | 14.9 Million | 15.16 Million | 15.39 Million | 15.57 Million |
| Weighted Average Shares Outstanding (Diluted) | 14.29 Million | 14.56 Million | 14.9 Million | 15.16 Million | 15.39 Million | 15.61 Million |
| Gross Margin | 0.85 | 0.78 | 0.76 | 0.77 | 0.78 | 0.82 |
| EBIT Margin | -0.02 | -0.01 | -0.02 | -0.04 | -0.13 | -0.09 |
| Profit Margin | -0.16 | -0.13 | -0.16 | -0.18 | -0.27 | -0.17 |
| EBITDA | -710.85 Thousand | 332.91 Thousand | -857.83 Thousand | -1.55 Million | -4.64 Million | -8.19 Million |
| Earnings Before Tax Margin | -0.16 | -0.14 | -0.21 | -0.17 | -0.27 | -0.18 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 9.84 Million | 8.49 Million | 9.35 Million | 39.55 Million | 10.08 Million | 10.88 Million |
| Cost of Revenue | 2.85 Million | 2.72 Million | 2.72 Million | 11 Million | 1.76 Million | 1.52 Million |
| Gross Profit | 6.99 Million | 5.77 Million | 6.62 Million | 28.54 Million | 8.32 Million | 9.36 Million |
| Operating Expenses | 8.23 Million | 7.87 Million | 8.71 Million | 35.03 Million | 10.18 Million | 9.34 Million |
| Selling, General and Administrative Expenses | 7.17 Million | 6.71 Million | 7.45 Million | - | 7.08 Million | 7.04 Million |
| Research and Development Expenses | 1.05 Million | 1.15 Million | 1.26 Million | - | 1.92 Million | 1.14 Million |
| Other Expenses | 1.09 Million | 1.11 Million | 4.53 Million | 2.82 Million | 1.17 Million | 981.8 Thousand |
| Cost and Expenses | 11.08 Million | 10.59 Million | 11.44 Million | 46.03 Million | 11.95 Million | 10.86 Million |
| Operating Income | -1.23 Million | -2.09 Million | -2.08 Million | -6.48 Million | -1.86 Million | 22.85 Thousand |
| Interest Expense | 126.34 Thousand | 118.52 Thousand | 178.79 Thousand | 667.86 Thousand | 110.08 Thousand | 192.63 Thousand |
| Income Tax Expense | 11.44 Thousand | 11.44 Thousand | 24.95 Thousand | 45.76 Thousand | 6938.00 | 6937.00 |
| Earnings before Tax | -1.09 Million | -1.89 Million | -6.27 Million | -6.28 Million | -1.05 Million | 869.09 Thousand |
| Net Income | -1.08 Million | -1.94 Million | -6.29 Million | -6.27 Million | -1.04 Million | 872.2 Thousand |
| Earnings Per Share Basic | -0.08 | -0.14 | -0.44 | - | -0.07 | 0.06 |
| Earnings Per Share Diluted | -0.08 | -0.14 | -0.44 | - | -0.07 | 0.06 |
| Weighted Average Shares Outstanding | 14.11 Million | 14.09 Million | 14.16 Million | 14.29 Million | 14.27 Million | 14.39 Million |
| Weighted Average Shares Outstanding (Diluted) | 14.11 Million | 14.09 Million | 14.16 Million | 14.29 Million | 14.27 Million | 14.55 Million |
| Gross Margin | 0.71 | 0.68 | 0.71 | 0.72 | 0.82 | 0.86 |
| EBIT Margin | 0.02 | -0.08 | -0.09 | - | -0.05 | 0.21 |
| Profit Margin | -0.11 | -0.23 | -0.67 | -0.16 | -0.10 | 0.08 |
| EBITDA | 186.05 Thousand | -663.81 Thousand | -854.9 Thousand | - | -521.9 Thousand | 2.26 Million |
| Earnings Before Tax Margin | -0.13 | -0.25 | -0.22 | -0.16 | -0.19 | 0.00 |
PAVS
EKDHF
6255
ATMP3
007590
SLV